Booster Immunization Improves Memory B Cell Responses in Older Adults Unresponsive to Primary SARS-CoV-2 Immunization

被引:8
作者
Verheul, Marije K. [1 ]
Nijhof, Kim H. [1 ]
de Zeeuw-Brouwer, Mary-lene [1 ]
Duijm, Geraly [1 ]
ten Hulscher, Hinke [1 ]
de Rond, Lia [1 ]
Beckers, Lisa [1 ]
Eggink, Dirk [2 ]
Van Tol, Sophie [2 ]
Reimerink, Johan [2 ]
Boer, Mardi [1 ]
Van Beek, Josine [1 ]
Rots, Nynke [1 ]
Van Binnendijk, Rob [1 ]
Buisman, Anne-Marie [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Ctr Immunol Infect Dis & Vaccines, NL-3721 MA Bilthoven, Netherlands
[2] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Ctr Infect Dis Res Diagnost & Lab Surveillance, WHO COVID 19 Reference Lab, NL-3721 MA Bilthoven, Netherlands
关键词
memory B cells; SARS-CoV-2; older adults; coronavirus; booster; primary vaccination; antibodies; COHORT PROFILE; IMMUNOGENICITY; INFECTION; VACCINES; NUMBERS; AGE;
D O I
10.3390/vaccines11071196
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The generation of a specific long-term immune response to SARS-CoV-2 is considered important for protection against COVID-19 infection and disease. Memory B cells, responsible for the generation of antibody-producing plasmablasts upon a new antigen encounter, play an important role in this process. Therefore, the induction of memory B cell responses after primary and booster SARS-CoV-2 immunizations was investigated in the general population with an emphasis on older adults. Participants, 20-99 years of age, due to receive the mRNA-1273 or BNT162b2 SARS-CoV-2 vaccine were included in the current study. Specific memory B cells were determined by ex vivo ELISpot assays. In a subset of participants, antibody levels, avidity, and virus neutralization capacity were compared to memory B cell responses. Memory B cells specific for both Spike S1 and receptor-binding domain (RBD) were detected in the majority of participants following the primary immunization series. However, a proportion of predominantly older adults showed low frequencies of specific memory B cells. Booster vaccination resulted in a large increase in the frequencies of S1- and RBD-specific memory B cells also for those in which low memory B cell frequencies were detected after the primary series. These data show that booster immunization is important for the generation of a memory B cell response, as a subset of older adults shows a suboptimal response to the primary SARS-CoV-2 immunization series. It is anticipated that these memory B cells will play a significant role in the immune response following viral re-exposure.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Immune response to SARS-CoV-2 variants after immunization with different vaccines in Mexico
    Garay, Erika
    Whelan, Sean P. J.
    Dubois, Rebecca M.
    O'Rourke, Sara M.
    Salgado-Escobar, Angel Eduardo
    Munoz-Medina, Jose Esteban
    Arias, Carlos F.
    Lopez, Susana
    EPIDEMIOLOGY & INFECTION, 2024, 152
  • [32] Adenosine deaminase augments SARS-CoV-2 specific cellular and humoral responses in aged mouse models of immunization and challenge
    Gary, Ebony N.
    Tursi, Nicholas J.
    Warner, Bryce M.
    Cuismano, Gina
    Connors, Jennifer
    Parzych, Elizabeth M.
    Griffin, Bryan D.
    Bell, Matthew R.
    Ali, Ali R.
    Frase, Drew
    Hojecki, Casey E.
    Canziani, Gabriela A.
    Chaiken, Irwin
    Kannan, Toshitha
    Moffat, Estella
    Embury-Hyatt, Carissa
    Wooton, Sarah K.
    Kossenkov, Andrew
    Patel, Ami
    Kobasa, Darwyn
    Kutzler, Michele A.
    Haddad, Elias K.
    Weiner, David B.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Combined immunization with SARS-CoV-2 spike and SARS-CoV nucleocapsid protects K18-hACE2 mice but increases lung pathology
    Kim, Jaekwan
    Kachko, Alla
    Selvaraj, Prabhuanand
    Rotstein, David
    Stauft, Charles Brandon
    Rajasagi, Naveen
    Zhao, Yangqing
    Wang, Tony
    Major, Marian
    NPJ VACCINES, 2025, 10 (01)
  • [34] Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination
    Pinder, Christopher L.
    Jankovic, Dylan
    Fox, Thomas A.
    Kirkwood, Amy
    Enfield, Louise
    Alrubayyi, Aljawharah
    Touizer, Emma
    Ford, Rosemarie
    Pocock, Rachael
    Shin, Jin-Sup
    Ziegler, Joseph
    Thomson, Kirsty J.
    Ardeshna, Kirit M.
    Peppa, Dimitra
    McCoy, Laura E.
    Morris, Emma C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (06) : 1091 - 1103
  • [35] HIV-related immune activation attenuates polyfunctional IgG and memory B-cell responses to Tdap immunization during pregnancy
    Taton, Martin
    Willems, Fabienne
    Widomski, Cyprien
    Georges, Daphnee
    Martin, Charlotte
    Jiang, Yiwei
    Renard, Katty
    Konopnicki, Deborah
    Cogan, Alexandra
    Necsoi, Coca
    Matagne, Andre
    De Wit, Stephane
    Ackerman, Margaret E.
    Marchant, Arnaud
    Dauby, Nicolas
    EBIOMEDICINE, 2024, 104
  • [36] Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
    Marking, Ulrika
    Havervall, Sebastian
    Greilert-Norin, Nina
    Ng, Henry
    Blom, Kim
    Nilsson, Peter
    Phillipson, Mia
    Hober, Sophia
    Nilsson, Charlotta
    Mangsbo, Sara
    Christ, Wanda
    Klingstrom, Jonas
    Gordon, Max
    Aberg, Mikael
    Thalin, Charlotte
    VACCINES, 2022, 10 (03)
  • [37] Robust and persistent B-cell responses following SARS-CoV-2 vaccine determine protection from SARS-CoV-2 infection
    Byrne, Joanne
    Gu, Lili
    Garcia-Leon, Alejandro
    Gaillard, Colette Marie
    Saini, Gurvin
    Alalwan, Dana
    Tomas-Cortazar, Julen
    Kenny, Grace
    Donohue, Sean
    Reynolds, Bearach
    O'Gorman, Tessa
    Landay, Alan
    Doran, Peter
    Stemler, Jannik
    Koehler, Philipp
    Cox, Rebecca Jane
    Olesen, Ole F.
    Lelievre, Jean-Daniel
    O'Broin, Cathal
    Savinelli, Stefano
    Feeney, Eoin R.
    O'Halloran, Jane A.
    Cotter, Aoife
    Horgan, Mary
    Kelly, Christine
    Sadlier, Corrina
    de Barra, Eoghan
    Cornely, Oliver A.
    Gautier, Virginie
    Mallon, Patrick W. G.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [38] The Comparability of Anti-SARS-CoV-2 IgG Levels Measured with Different Immunoassays Varies over Time after Primary BNT162b2 Vaccination and Homologous Booster Immunization
    Salvagno, Gian Luca
    Lippi, Giuseppe
    MICROBIOLOGY SPECTRUM, 2022, 10 (06):
  • [39] Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
    Kurt, Feyza Guel Oezbay
    Lepper, Alisa
    Gerhards, Catharina
    Roemer, Mathis
    Lasser, Samantha
    Arkhypov, Ihor
    Bitsch, Rebekka
    Bugert, Peter
    Altevogt, Peter
    Gouttefangeas, Cecile
    Neumaier, Michael
    Utikal, Jochen
    Umansky, Viktor
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [40] Could BCG vaccine provide immunization against COVID-19? A potential relationship between Mycobacterium immunization and SARS-CoV-2
    Ozkaya, Sevket
    Uzar, Tugce
    Man, Irem Kara
    Ozen, S. Bade
    Dirican, Adem
    MINERVA PNEUMOLOGICA, 2020, 59 (03) : 49 - 54